Matthew Shaulis, Chief Commercial Officer and US President, Hansa Biopharma AB, has decided to leave the company in late September. Effective immediately, the Commercial Leadership team will report to Søren Tulstrup, President and CEO. A search is underway for a new CCO and US President.   Søren Tulstrup, President and CEO, Hansa Biopharma remarked, “Matt has been a fantastic addition to the Hansa executive team and has made significant contributions across the organization over the past...